This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, The Chinese University of Hong Kong, Université´ D'aix-Marseille. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2019
Title: K W Lo: Innovator in Cancer Treatment
Introduction
K W Lo is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic methods. His work focuses on the use of amphiphilic dendrimers complexed with siRNA to enhance cancer treatment efficacy.
Latest Patents
K W Lo holds a patent for "Amphiphilic dendrimers complexed with siRNA for treatment of cancer." This invention pertains to biodegradable amphiphilic dendriplexes that exhibit enhanced siRNA delivery. The dendriplexes containing Bcl3 siRNA have been shown to inhibit cancer cell and tumor growth both in vitro and in vivo without causing toxicity. This groundbreaking method provides a therapeutic approach for treating nasopharyngeal carcinoma by administering a therapeutic amount of these dendrimers complexed with Bcl3 siRNA. Additionally, pharmaceutical compositions containing these amphiphilic dendrimers are also part of his patent.
Career Highlights
K W Lo has had a distinguished career, working at notable institutions such as The Chinese University of Hong Kong and Versitech, Inc. His research has significantly advanced the understanding and treatment of cancer, particularly through innovative drug delivery systems.
Collaborations
Throughout his career, K W Lo has collaborated with esteemed colleagues, including Alice S T Wong and Jing Ma. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
K W Lo's innovative work in the field of cancer treatment exemplifies the impact of scientific research on healthcare. His patented methods and collaborative efforts continue to pave the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile